Evidence map›Paper›PMID 31159319›Full record

ArticleNutrients2019

Human Enriched Serum Following Hydrolysed Collagen Absorption Modulates Bone Cell Activity: from Bedside to Bench and Vice Versa.

Fabien Wauquier, Audrey Daneault, Henri Granel, Janne Prawitt, Véronique Fabien Soulé, Juliette Berger, Bruno Pereira, Jérôme Guicheux, Gael Y Rochefort, Nathalie Meunier and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Fabien WauquierINRA, UMR 1019, UNH, CRNH Auvergne, F-63009 Clermont-Ferrand, France. Fabien_Wauquier@gmx.fr.
Audrey DaneaultINRA, UMR 1019, UNH, CRNH Auvergne, F-63009 Clermont-Ferrand, France. audrey.daneault@gmail.com.
Henri GranelINRA, UMR 1019, UNH, CRNH Auvergne, F-63009 Clermont-Ferrand, France. henri.granel@inra.fr.
Janne PrawittRousselot BVBA, Meulestedekaai 81, 9000 Gent, Belgium. janne.prawitt@rousselot.com.
Véronique Fabien SouléRousselot SAS, 4 rue de l'abreuvoir, 92400 Courbevoie, France. vfabiensoule@syndifrais.com.
Juliette BergerCRB Auvergne, 1 place Lucie et Raymond Aubrac, 63003 Clermont-Ferrand Cedex 1, France CHUClermont-Ferrand, CHU Estaing, Hématologie Biologique, 1 place Lucie et Raymond Aubrac,63003 Clermont-Ferrand Cedex 1, CHU Clermont-Ferrand, CHU Estaing, Université Clermont Auvergne,Equipe d'Accueil 7453 CHELTER, CHU Estaing, 1 place Lucie et Raymond Aubrac,F-63003 Clermont-Ferrand Cedex 1, France. jberger@chu-clermontferrand.fr.
Bruno PereiraUniversity hospital Clermont-Ferrand, Biostatistics Unit (DRCI), 58 rue Montalembert, 63000 Clermont-Ferrand, France. bpereira@chu-clermontferrand.fr.
Jérôme GuicheuxInserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, 44000 Nantes, France. jerome.guicheux@inserm.fr.
Gael Y RochefortInserm, UMR 1229, RMeS, Regenerative Medicine and Skeleton, Université de Nantes, ONIRIS, 44000 Nantes, France. gael.rochefort@gmail.com.
Nathalie MeunierChu Clermont-Ferrand, Centre De Recherche En Nutrition Humaine Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France. nmeunier@chu-clermontferrand.fr.
Adeline BlotChu Clermont-Ferrand, Centre De Recherche En Nutrition Humaine Auvergne, 58 rue Montalembert, 63000 Clermont-Ferrand, France. ablot@chu-clermontferrand.fr.
Yohann WittrantINRA, UMR 1019, UNH, CRNH Auvergne, F-63009 Clermont-Ferrand, France. yohann.wittrant@inra.fr.
Centre Hospitalier Universitaire de Clermont-Ferrand · FRUniversité Clermont Auvergne · FRInserm · FRADIR Association · FRHasselt University · BE

Funding

Association Nationale de la Recherche et de la Technologie COLOS
6 · The paper itself

Abstract

Collagen proteins are crucial components of the bone matrix. Since collagen-derived products are widely used in the food and supplement industry, one may raise the question whether collagen-enriched diets can provide benefits for the skeleton. In this study, we designed an innovative approach to investigate this question taking into account the metabolites that are formed by the digestive tract and appear in the circulation after ingestion of hydrolysed collagen. Blood samples collected in clinical and pre-clinical trials following ingestion and absorption of hydrolysed collagen were processed and applied on bone-related primary cell cultures. This original ex vivo methodology revealed that hydrolysed collagen-enriched serum had a direct impact on the behaviour of cells from both human and mouse origin that was not observed with controls (bovine serum albumin or hydrolysed casein-enriched serum). These ex vivo findings were fully in line with in vivo results obtained from a mouse model of post-menopausal osteoporosis. A significant reduction of bone loss was observed in mice supplemented with hydrolysed collagen compared to a control protein. Both the modulation of osteoblast and osteoclast activity observed upon incubation with human or mouse serum ex vivo and the attenuation of bone loss in vivo, clearly indicates that the benefits of hydrolysed collagen for osteoporosis prevention go beyond the effect of a simple protein supplementation.

Indexed as

3T3 CellsAnimalsBone and BonesBone DensityBone Marrow CellsCell ProliferationCollagenDietary SupplementsFemaleGene Expression RegulationHumansHydrolysisLeukocytes, MononuclearMiceMice, Inbred C3HOsteoclastsCollagenRANK Ligandabsorptionbonecollagen peptideshydrolysed collagenmetabolitesnutritionosteoporosis

Identifiers

PMID31159319
PMCPMC6627680
OpenAlexW2947071934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.